These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6420514)

  • 21. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of amantadine on dopaminergic neurons in discrete regions of the rat brain.
    Toide K
    Pharm Res; 1990 Jun; 7(6):670-2. PubMed ID: 1973292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
    Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.
    Bardo MT; Bowling SL; Pierce RC
    Psychopharmacology (Berl); 1990; 101(3):338-43. PubMed ID: 2163539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat.
    Westfall TC; Naes L; Paul C
    J Pharmacol Exp Ther; 1983 Jan; 224(1):199-205. PubMed ID: 6848743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP; Wolf ME; Roth RH
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
    Yamada K; Demarest KT; Moore KE
    Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat.
    Kalivas PW; Duffy P
    Biol Psychiatry; 1989 Apr; 25(7):913-28. PubMed ID: 2541803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of the relationship between the dopaminergic and electroencephalographic effects of gamma-butyrolactone.
    Snead OC
    Neuropharmacology; 1982 Jun; 21(6):539-43. PubMed ID: 7110537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
    Durham RA; Johnson JD; Moore KE; Lookingland KJ
    Brain Res; 1996 Sep; 732(1-2):113-20. PubMed ID: 8891275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for dopamine autoreceptors in mesocortical dopamine neurons.
    Fadda F; Gessa GL; Marcou M; Mosca E; Rossetti Z
    Brain Res; 1984 Feb; 293(1):67-72. PubMed ID: 6423212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain.
    Hörtnagl H; Pichler L; Holzer-Petsche U; Hornykiewicz O; Kobinger W
    Eur J Pharmacol; 1984 Nov; 106(2):335-44. PubMed ID: 6152218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?
    Vulto AG; Fowler CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):349-53. PubMed ID: 2877399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles.
    Marek KL; Roth RH
    Eur J Pharmacol; 1980 Mar; 62(2-3):137-46. PubMed ID: 6769681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1984 Nov; 36(11):748-52. PubMed ID: 6150978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presynaptic control of dopamine metabolism in the nucleus accumbens. Lack of effect of buspirone as demonstrated using in vivo voltammetry.
    Louilot A; Le Moal M; Simon H
    Life Sci; 1987 May; 40(20):2017-24. PubMed ID: 3573992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.